BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10816681)

  • 1. Effective treatment of pruritus with naltrexone, an orally active opiate antagonist.
    Metze D; Reimann S; Luger TA
    Ann N Y Acad Sci; 1999 Oct; 885():430-2. PubMed ID: 10816681
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases.
    Metze D; Reimann S; Beissert S; Luger T
    J Am Acad Dermatol; 1999 Oct; 41(4):533-9. PubMed ID: 10495371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone: a case report of pruritus from an antipruritic.
    Sullivan JR; Watson A
    Australas J Dermatol; 1997 Nov; 38(4):196-8. PubMed ID: 9431714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
    Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR
    Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective opiate-receptor antagonist therapy of cholestatic pruritus induced by an oral contraceptive.
    Kunzmann S; Kullak-Ublick GA; Greiner A; Jeschke R; Hebestreit H
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):596-9. PubMed ID: 15861022
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy.
    Neuberger J; Jones EA
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1393-4. PubMed ID: 11692070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.
    Chang Y; Golkar L
    Pediatr Dermatol; 2008; 25(3):403-4. PubMed ID: 18577062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory vulvovaginal pruritus with naltrexone, a specific opiate antagonist.
    Böttcher B; Wildt L
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():115-6. PubMed ID: 24388844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pruritus responsive to naltrexone in a patient with cholestatic liver disease.
    Mozer-Glassberg Y; Hojsak I; Zevit N; Shapiro R; Shamir R
    Isr Med Assoc J; 2011 Feb; 13(2):111-2. PubMed ID: 21443039
    [No Abstract]   [Full Text] [Related]  

  • 12. Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease.
    Kumar N; Garg N; Bailey A
    J Palliat Med; 2013 Feb; 16(2):122-3. PubMed ID: 23391399
    [No Abstract]   [Full Text] [Related]  

  • 13. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis.
    Jones EA; Dekker LR
    Gastroenterology; 2000 Feb; 118(2):431-2. PubMed ID: 10648471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].
    Brune A; Metze D; Luger TA; Ständer S
    Hautarzt; 2004 Dec; 55(12):1130-6. PubMed ID: 15517116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The uses of naltrexone in dermatologic conditions.
    Lee B; Elston DM
    J Am Acad Dermatol; 2019 Jun; 80(6):1746-1752. PubMed ID: 30582992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic hepatocellular carcinoma with paraneoplastic itch: effective treatment with naltrexone.
    Chia BK; Tey HL
    J Drugs Dermatol; 2014 Dec; 13(12):1440. PubMed ID: 25607785
    [No Abstract]   [Full Text] [Related]  

  • 17. Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study.
    Pauli-Magnus C; Mikus G; Alscher DM; Kirschner T; Nagel W; Gugeler N; Risler T; Berger ED; Kuhlmann U; Mettang T
    J Am Soc Nephrol; 2000 Mar; 11(3):514-519. PubMed ID: 10703675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis.
    Roginsky G; Alexoff A; Ehrenpreis ED
    J Clin Gastroenterol; 2015 Oct; 49(9):794-5. PubMed ID: 26280708
    [No Abstract]   [Full Text] [Related]  

  • 19. Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis.
    Heyer G; Dotzer M; Diepgen LT; Handwerker OH
    Pain; 1997 Nov; 73(2):239-243. PubMed ID: 9415511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.